“Outcome of Combined Temozolomide CCNU Versus Temozolomide (Standard or Extended) For Patients With Methylated MGMT Glioblastoma”. Journal of Cancer Research Updates 15, no. 3 (July 15, 2026): 197–205. Accessed July 16, 2026. https://neoplasiaresearch.com/index.php/jcru/article/view/970.